Snowball logo
logo
1749

AbClon Inc

174900 KQ
19,680.00+460.00  (2.39%)
Estimate
Beta
0.767
Growth
Revenue, YoY
5.22%
Net income, YoY
53.48%
FCF, YoY
53.06%
About the company
Ticker
174900
ISIN
KR7174900001
Country
Other
Sector (GICS)
Energy
AbClon Inc. engages in the research and development of antibody drugs in South Korea and Sweden. The company's products in pipeline include NEST platform technology products for breast and gastric cancers; AffiMab platform technology products for colon cancer and autoimmune diseases; and CAR-T platform technology products for hematologic and ovarian cancers. AbClon Inc. was founded in 2010 and is based in Seoul, South Korea.

Frequently asked questions

What sector does AbClon Inc (174900) operate in?

AbClon Inc belongs to the Energy sector and operates in the Biotechnology industry.

What is AbClon Inc (174900) current stock price?

As of the latest data, AbClon Inc stock price is ₩19,680, with a previous close of ₩19,220. AbClon Inc gained ₩460 in the last trading session, representing a 2.39% increase.

What is AbClon Inc (174900) current market capitalization?

AbClon Inc market cap is approximately 392.13 billion.

Does AbClon Inc (174900) pay dividends?

No. AbClon Inc does not pay a dividend.

What is AbClon Inc (174900) beta (volatility) score?

AbClon Inc has a beta of 0.767, indicating lower volatility than the overall market.